Suppr超能文献

结构基础研究 X77 抑制 HCoV-NL63 主蛋白酶 M

Structural basis for the inhibition of the HCoV-NL63 main protease M by X77.

机构信息

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Applied Biology Laboratory, College of Pharmaceutical and Biological Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China.

出版信息

Biochem Biophys Res Commun. 2024 Sep 10;724:150231. doi: 10.1016/j.bbrc.2024.150231. Epub 2024 Jun 6.

Abstract

Human coronaviruses are a group of pathogens that primarily cause respiratory and intestinal diseases. Infection can easily cause respiratory symptoms, as well as a variety of serious complications. There are several types of human coronaviruses, such as SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, and SARS-CoV-2. The prevalence of COVID-19 has led to a growing focus on drug research against human coronaviruses. The main protease (M) from human coronaviruses is a relatively conserved that controls viral replication. X77 was discovered to have extremely high inhibitory activity against SARS-CoV-2 M through the use of computer-simulated docking. In this paper, we have resolved the crystal structure of the HCoV-NL63 M complexed with X77 and analyzed their interaction in detail. This data provides essential information for solving their binding modes and their structural determinants. Then, we compared the binding modes of X77 with SARS-CoV-2 M and HCoV-NL63 M in detail. This study illustrates the structural basis of HCoV-NL63 M binding to the inhibitor X77. The structural insights derived from this study will inform the development of new drugs with broad-spectrum resistance to human coronaviruses.

摘要

人类冠状病毒是一组主要引起呼吸道和肠道疾病的病原体。感染很容易引起呼吸道症状,以及各种严重的并发症。有几种类型的人类冠状病毒,如 SARS-CoV、MERS-CoV、HCoV-229E、HCoV-OC43、HCoV-NL63、HCoV-HKU1 和 SARS-CoV-2。COVID-19 的流行导致人们越来越关注针对人类冠状病毒的药物研究。人类冠状病毒的主要蛋白酶(M)是一种相对保守的蛋白酶,控制着病毒的复制。通过计算机模拟对接,发现 X77 对 SARS-CoV-2 M 具有极高的抑制活性。在本文中,我们解析了与 X77 结合的 HCoV-NL63 M 的晶体结构,并详细分析了它们的相互作用。这些数据为解决它们的结合模式及其结构决定因素提供了重要信息。然后,我们详细比较了 X77 与 SARS-CoV-2 M 和 HCoV-NL63 M 的结合模式。这项研究说明了 HCoV-NL63 M 与抑制剂 X77 结合的结构基础。这项研究得出的结构见解将为开发对人类冠状病毒具有广谱耐药性的新药提供信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验